Clozapine augmentation for treatment-resistant schizoaffective disorder

To systematically review the clinical effects, efficacy and safety of pharmacological augmentation for clozapine in treatment-resistant schizoaffective disorder.

This is a protocol.

Health topics:

Mental health > Schizophrenia & psychosis > Antipsychotic medication: atypical

Mental health > Schizophrenia & psychosis > Management issues

Insurance medicine > Costs > Mental health

Insurance medicine > Sick Leave > Mental health

facebook
twitter
whatsapp
email

Don't show again

What role do you identify with the most?

General public, patient, or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.